Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of hPG80 (Circulating Progastrin) as a Blood Biomarker for High-grade Glial Tumors

NCT05157594 is registered in ClinicalTrials.gov with Centre Jean Perrin as lead sponsor.

NCT NCT05157594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05157594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of hPG80 (Circulating Progastrin) as a Blood Biomarker for High-grade Glial Tumors
Lead sponsor
Centre Jean Perrin
Phase
Observational
Overall status
Completed
Start date
February 14, 2022
Completion date
August 19, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glial cell tumors